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BB rats spontaneously develop insulin-dependent, ketosis-prone diabetes mel- 
litus (DM)) The i r  disease is of  au to immune etiology, since it is characterized by: 
(a) lymphocytic and rnacrophage inflammation of  pancreatic islets (1), (b) circu- 
lating autoantibodies that bind to pancreatic islets of  Langerhans (2), (c) increased 
incidence of  Ia ant igen-bear ing T lymphocytes associated with the development 
of  diabetes (3), (d) progressive and selective destruction of  insulin-producing 
beta ceils (1, 4), (e) the ability to transfer disease to immunodeficient  animals 
with concanavalin A-activated splenic lymphocytes (5), and ( f )  selective destruc- 
tion of  beta cells in transplanted islets (6); in addition, it can be prevented with 
many forms of  immunotherapy (7). BB rats also exhibit a profound T cell 
lymphocytopenia with an almost total lack of  circulating T lymphocytes, al though 
their thymocytes are normal in number  and cell surface phenotype (8). In 
breeding studies, we and others (9, 10) have shown that at least two genes 
contribute to the development of  diabetes in the BB rat. One is autosomal 
recessive and determines the profound T cell immunodeficiency present in 
affected rats at birth. The  second is linked to RTI, the rat major histocompati- 
bility complex (MHC). 
To  fur ther  define the BB rat's RTl-linked diabetogenic gene, we asked whether  
there are MHC differences between BB rats and control strains at the genomic 
level (as determined by studying restriction fragment  length polymorphism 
[RFLP]) that are related to MHC diabetogenicity, as determined in breeding 
studies. Using a class II H-2 A-alpha probe, we previously reported (11) the 
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existence of  four  polymorphic  MHC types in the control  BBN population,  which 
reflects the colony f rom which the BB rat  was derived,  only one of  which was 
found  in BB rats. We also r epor t ed  prel iminary results (12) using class I, II, and 
III MHC probes to find polymorphisms that fu r the r  subdivide the BB and BBN 
populat ion.  In this paper  we ex tend  those prel iminary findings and characterize 
five RFLP-def ined  MHC types in the BBN populat ion and a distinct RFLP- 
def ined MHC type present  only in BB rats, using a class I MHC probe.  We 
evaluated the diabetogenicity of  these RFLP-def ined  MHC chromosome types 
in a breeding  study and de te rmined  the serologic RT!  phenotypes  encoded  by 
these chromosomes  using monoclonal  antibodies. These  findings allow us to 
provide prel iminary localization o f  the MHC-linked diabetogenic gene of  rats as 
well as insight into the organization of  class II genes in the RT1 complex. T h e  
organization of  these studies is schematized in Fig. 1. 
Ma te r i a l s  a n d  M e t h o d s  
Animals. BB/O rats and Wistar control rats (here termed BBN) were kindly provided 
by Dr. Pierre Thibert (Department of National Health and Welfare, Ottawa, Canada) or 
bred from his stock in the animal facility at the Joslin Diabetes Center. BB/W rats from 
sublines with a high incidence of diabetes (NC, PA, FA, BF) or low incidence sublines 
(WA, WC) were provided by Dr. A. A. Like (University of Massachusetts Medical Center, 
Worcester, MA). Animals from a new strain of diabetic rats (BB-Hooded) with a 95% 
incidence of diabetes, developed by Dr. J. Logothetopoulos (Best and Banting Institute, 
Toronto, Canada), were also provided by Dr. Thibert. BB/O and BBN rats were co- 
derived from the same original outbred colony by selection for (BB/O) or against (BBN) 
the development of diabetes. Both strains are maintained as outbred closed colonies. BB/ 
W rats have been inbred by brother-sister mating for 16+ generations. Low-incidence 
BB/W sublines were split off from the high incidence BB/W lines after six generations of 
inbreeding by selecting against the development of diabetes, and are often referred to as 
W-line rats. BBN and W-line rats do not exhibit the T cell immunodeficiency present in 
the diabetes-prone BB/O, BB/W (high incidence sublines), and BB-Hooded rats. Wistar 
Furth (WF) Buffalo, Lewis, and ACI rats were obtained from Harlan Sprague Dawley, 
Inc. (Indianapolis, IN). Animals were housed according to NIH guidelines at the animal 
facility at the Joslin Diabetes Center and provided ad libitum commercial rat chow and 
water. Diabetes-prone animals were screened every 2-3 d for glycosuria and were 
determined to be diabetic if they had serum glucose values >300 mg/dl on two consecutive 
days. Diabetic animals were maintained with daily doses of Lente insulin (Eli Lilly & Co., 
Indianapolis, IN). 
Probes. The A-alpha probe was isolated by Dr. A. Ben-Nun (Weitzman Institute, 
Rehovot, Israel) and is a 1.3 kb HindIII genomic fragment of the A-alpha region of 
C57BL/10 encoding part of the alpha 1 and all of the alpha 2, transmembrane and 
intracytoplasmic domains as well as intervening introns. The DC-beta probe was provided 
by Dr. P. Peterson (University of Uppsala, Uppsala, Sweden) and is a cDNA clone of a 
HLA-DC-Iike gene (13). The E-beta probe (subclone 8.48, kindly provided by Dr. L. 
Hood, California Institute of Technology, Pasadena, CA) is a 7.2 kb genomic fragment 
encoding the beta-1 and beta-2 domains of E d (14). The E-alpha probe used is a 1.4 kb 
BglII genomic fragment of a Pstl subclone of cosId-alpha-1 (kindly provided by Dr. R. 
Flavell, Biogen, Cambridge, M A) encoding the alpha-1 domain of E d (15). Three class I II 
genomic probes were used: probe f as well as a 6.7 kb BamHI fragment and a 2.5 kb 
BamHI fragment of cosmid E7 from the "sex-limited protein" area of H-2 (16, 17). The 
class I probe (S16) is a 500 basepair genomic fragment of the third coding block (C-2 
domain) of H-2L d (18). Because of high sequence homology in MHC genes among 
mammals, it is assumed though not proved that these probes hybridize with genes in rats 
homologous to the MHC genes in mice and humans (19-22). 
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DNA Isolation and Determination of RFLP. ~1 cm of rat tail was frozen in liquid 
nitrogen and stored at - 80°C  until use. The tail was cut into 1-2-ram slices, placed on 
ice in 2 ml 0.1 M NaCl, 0.2 M sucrose, 0.01 M EDTA, 0.03 M Tris-HC1, pH 8, and 
homogenized using a Polytron (Brinkman Instruments Co., Westbury, NY). Then, 0.5 ml 
of 0.25 M EDTA, 2.5% sodium dodecyl sulfate (SDS), 0.5 M Tris-HCI, pH 9.2 was added 
and the mixture incubated at 65°C for 30 min. 0.3 ml 8 M potassium acetate was added, 
the mixture incubated for 1 h on ice, and the aqueous solution was extracted twice with 
5 ml 100:1 chloroform/isoamyl alcohol. DNA was precipitated from the aqueous phase 
with a final concentration of 50% ethanol for 10 rain at room temperature. The methods 
for RFLP analysis have been previously described (11) except as noted below. For class I 
RFLP analysis, 25 ug of DNA were digested to completion using restriction enzyme 
EcoRI (New England BioLabs, Beverly, MA) in appropriate buffer. DNA fragments were 
separated on 0.7% agarose gels, transferred to nitrocellulose filters, and hybridized with 
3zP-labeled DNA probe. All hybridizations were done at high stringency, with final washes 
at 50°C in 30 mM NaCI, 3 mM trisodium citrate, and 0.1% SDS. Autoradiography was 
used to visualize bands of specifically bound, labeled probe. 
Determination of T Cell Lymphopenia. A rapid screening assay for lymphopenia had 
been developed and found (9) to be both sensitive and specific compared with our 
standard assay. Briefly, 0.125 ml of blood was collected into heparinized Natelson tubes 
and mixed with 0.125 ml RPMI 1640 plus 4 mg/ml gentamycin sulfate (RPMI plus G) in 
96-well V-bottomed plates. The plates were centrifuged at 1,000 g and the supernatants 
were aspirated. The anti-rat T cell monoclonal antibody OX19 (Accurate Chemical & 
Scientific Corp., Westbury, NY) was diluted 1:100 with RPMI plus G and 0.5% bovine 
serum albumin; 0.05 ml was added to each well, incubated for 45 min at 4°C, and washed 
twice with 0.2 ml RPMI plus G. A second incubation, with 0.05 ml fluorescein-conjugated 
F(ab')2 goat anti-mouse IgG (diluted 1:10 in rat serum; Tago, Inc., Burlingame, CA), 
was for 45 rain at 4°C. The cells were washed three times with RPMI plus G. The red 
cell/white cell pellet was diluted 10-fold with phosphate-buffered saline, and 105 cells 
were evaluated for the presence of T lymphocytes using an Epics V flow cytometer 
(Coulter Electronics Inc., Hialeah, FL) as previously described (9). Typically, nonlympho- 
penic animals have a 5-10-fold higher percentage of OX 19-positive cells than do lympho- 
penic animals by this assay. Known lymphopenic and nonlymphopenic animals were 
included in each assay as positive and negative controls. 
RT1 Typing. Class I MHC typing (RT1.A) was determined by indirect immunofluo- 
rescence on Ficoll-Hypaque-isolated peripheral blood mononuclear cells as previously 
described (9) using monoclonal antibodies LWF.415 (anti-RT1.A u) and AP. 1.1.13 (anti- 
RTI.Aa). Class II MHC typing (RTI.B and RTI.D) was determined on Ficoll-Hypaque 
density gradient (specific gravity, 1.090)-purified splenic mononuclear cells as follows. 
Surface immunoglobulin was capped in the presence of excess fluorescein-labeled rabbit 
anti-rat IgG (Cappel Laboratories, Cochranville, PA), diluted 1:25 in RPMI plus G 
containing 20% fetal bovine serum, for 1 h at 37°C. Capped cells were washed three 
times with phosphate-buffered saline plus 0.1% sodium azide (PBS plus Az) to prevent 
further capping. A second incubation was carried out in the presence of monoclonal 
antibody supernatants specific for RTI.B u (LW2.3C9) or RT1.D a (4D11) for 1 h at 4°C. 
The splenocytes were again washed three times in PBS plus Az and then incubated with 
an excess of rhodaminated rabbit anti-rat IgG (Cappel Laboratories) diluted 1:25 in PBS 
plus Az. Cells were washed three times with PBS plus Az and examined with a Leitz- 
Diavert microscope equipped for epifluorescence. A reaction was considered positive if 
>90% of cells exhibiting fluorescein capping (surface immunoglobulin-positive B cells) 
also exhibited rhodamine rim fluorescence (class II antigen). WF (RFI"), AC1 (RTla), 
Lewis (RTI~), and Buffalo (RT1 b) rats were used as positive or negative controls. These 
antibodies were either produced in Dr. E. Milford's laboratory (LWF.415, LW2.3C9, and 
4D11) or kindly provided by Dr. E. Blankenhorn (AP. 1.1.13) (University of Pennsylvania 
Medical School, Philadelphia, PA). The method used for class II RT1 typing was kindly 
provided by J. Kut, Brigham and Women's Hospital. 
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Data were analyzed using a CLINFO computer sytem (NIH GCRC No. 5M01 
RR00888-10CLR. 
Results  
RFLP Analysis Using Class H MHC Probes. We have previously reported (11) 
the existence of  class II MIqC polymorphisms in the BB (diabetes-prone) and 
BBN (control strain "BB normal") population using an A-alpha probe. To  
summarize, in the rats studied using restriction enzyme BamHI, the A-alpha 
(class II) probe hybridizes with two bands, designated "1" and "2". Using 
restriction enzyme EcoRI, the A-alpha probe also hybridizes with two bands, 
designated "a" and "b". Thus, using the A-alpha probe with BamHI and EcoRI, 
four polymorphic patterns are seen, which we have defined as type la (BamHI 
2.9 kb, EcoRI 8.2 kb), type lb  (BamHI 2.9 kb, EcoRI 1.7 kb), type 2a (BamHI 
2.4 kb, EcoRI 8.2 kb), and type 2b (BamHI 2.4 kb, EcoRI 1.7 kb). These RFLP 
patterns are inherited in a classic Mendelian fashion. The results of  our RFLP 
analysis using the A-alpha probe in BB, BBN, and Wistar Furth rats are presented 
in Table I. All diabetes-prone BB strain animals (BB/O, BB/W, and BB-Hooded 
rats In = 30]) are 2a/2a homozygotes. In the BBN population, la, lb, 2a, and 
2b chromosomes exist and most animals are heterozygotes (Table I). Analyzed 
in terms of  chromosomes, the population of BBN rats we studied consisted of 
48% 2a, 35% lb,  16% Ia, and 1% 2b chromosomes. (Since 2b rats are very rare 
and because we were unable to breed them, they have not been studied further.) 
Wistar Furth rats (WF), an inbred strain of rat bearing the RTL u haplotype, 
share A-alpha RFLP type 2a-defined homozygosity with BB rats. We used 10 
other restriction enzymes (Apal, BglII, EcoRV, HindIII, Kpnl, Pstl, PvuII, Sacl, 
Smal, Xhol) to try to subdivide 2a rats using the A-alpha probe, but, with all 
enzymes, BB/O, BBN 2a, and WF rats showed identical banding patterns. The 
same was true using enzyme Mspl for WF, BB/W, BB/O, and BB-Hooded rats. 
Other class II probes were used in an effort to further subdivide the BB and 
BBN rat population. A DC-beta probe with restriction enzymes BamHI and 
TABLE I 
A-Alpha-defined RFLP Types in BB, BBN, and WF Rats 
Chromosome type BBN (n) BB* (n) WF (n) 
2a/2a 30 30 3 
2b/2b  0 0 0 
l a / l a  2 0 0 
I b / l b  t3  0 0 
2 a / l a  10 0 0 
2 a / l b  22 0 0 
2a/2b 0 0 0 
l a / l b  16 0 0 
1 b /2b  2 0 0 
lb/2a* or l a /2b  32 0 0 
* BB rats included 18 BB/O rats, 6 BB hooded, 4 BB/W from high 
incidence litters, and 5 BB/W from low incidence litters. 
* These heterozygous types cannot be distinguished except in family 
studies. 22 of 22 of animals with this RFLP pattern are 1 b/2a according 
to such studies. 
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FIGURE l. Schematization of our experiments to define diabetogenic MHC haplotypes in 
the BB and BBN rat populations. Both strains were derived from the same outbred Wistar rat 
colony by selecting for the development of diabetes (BB) or against the development of 
diabetes (BBN). Class II RFLP analysis subdivides the control BBN rats into four subgroups 
(la, lb, 2a, and 2b), while BB rats exhibit one of these (2a). (2b BBN rats are not included in 
this figure since they are rare and we have not been able to breed them.) Class I RFLP analysis 
absolutely distinguishes BB (2a0) from BBN rats (2al, 2a2, la, lb). A breeding study was 
carried out to evaluate the diabetogenicity of the various RFLP-defined MHC haplotypes. 
EcoRI genera ted  the same data ( though different  band molecular sizes) as did 
the A-alpha probe  with restriction enzyme BamHI (distinguishing "1" BBN rats 
[ la  and lb] f rom 2a rats [BB/O, WF, and 2a BBN]). However ,  there  was no 
polymorphism analogous to that seen with A-alpha and EcoRI (12). An E-alpha 
probe  also genera ted  the same pat tern  o f  polymorphisms (though, again, differ- 
ent  molecular  sizes), with restriction enzymes BamHI and EcoRI, distinguishing 
la  and lb  rats f rom 2a rats (BB/O, WF, and BBN). However ,  no RFLP was 
evident  with enzyme Hindl I I  and PvuII using the E-alpha probe  (data not 
shown). An E-beta probe  showed no polymorphisms between BB/O,  WF, and 
la,  lb,  and 2a BBNs using restriction enzymes BamHI and EcoRI. In addition, 
we were unable to subdivide 2a rats using the E-beta probe  and the panel o f  11 
restriction enzymes ment ioned above for A-alpha (data not  shown). 
T o  summarize (Fig. 1), the A-alpha class II probe,  in concert  with restriction 
enzymes BamHI and EcoRI, generates RFLPs that subdivide the BBN population 
into la,  lb,  2a, and 2b rats. However ,  all BB rats exhibit the 2a A-alpha RFLP,  
as do all Wistar Furth rats. 
RFLP Analysis Using Class III MHC Probes. We were unable to detect  any 
polymorphisms between BB/O,  WF, and la, lb,  and 2a BBN rats using three  
H-2 S-region probes from the area coding for the "sex-limited protein"  (Slp) o f  
H-2 with restriction enzymes BamHI,  EcoRI, HindII I ,  Mspl, and PvuII  (data 
not  shown). These  probes have demonst ra ted  limited polymorphisms in mice 
(16). 
RFLP Analysis Using Class I MHC Probes. In contrast  to o ther  MHC probes, 
the S 16 class I MHC probe  allowed us to absolutely distinguish all BB from BBN 
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FIGURE 2. RFLP analysis using restriction enzyme EcoRI and the S16 class I probe in a lb 
BBN rat (lane I), la BBN (2), 2a2 BBN rat (3), 2al BBN rat (4), BB-Hooded rat (5), BB/W 
W-line rat (6), and a Wistar Furth rat (7). All BB substrains as well as Wistar Furth rats 
exhibited the same class I RFLP (termed 2a0) and could be distinguished from all BBN rats. 
Markers at right designate molecular sizes in kilobases 23.7, 9.5, 6.7, 2.3, and 2.0, from top 
to bottom. 
rats. At least five dif ferent  pat terns were evident  (Fig. 2) using the $16 probe  
and restriction enzyme EcoRI. BBN rats that exhibit  the A-alpha lb  RFLP had 
a distinctive band pat tern  (Fig. 2, lane 1) which we call class I RFLP lb.  BBN 
rats with the A-alpha la  RFLP had ano ther  pat tern  (Fig. 2, lane 2) which we 
designate la. T h e  A-alpha-def ined  type 2a RFLP can be divided into 2a! and 
2a2 forms using the S16 probe  in concer t  with EcoRI (Fig. 2, lanes 4 and 3, 
respectively). However ,  BB/O,  BB/W (including high-incidence sublines and the 
control  W line), BB-Hooded,  and Wistar Fur th  rats all shared a class I RFLP 
that we call form 2a0 (2a because they exhibi ted the 2a A-alpha RFLP,  and 0 
because they lacked bands in the 8 .0-9 .5  kb range where  all o ther  rats have at 
least one band). T h e  2a0 RFLP is shown in lanes 5 (BB-Hooded),  6 (BB/W low- 
incidence subline) and 7 (WF) of  Fig. 2. Similar distinguishing polymorphisms 
are evident  using restriction enzymes Xh01,  PvuII,  Smal, Pstl, Apal, Sacl, EcoRV, 
HindI I I ,  BglII, and Kpnl. T h e  2al  RFLP (Fig. 2, lane 4) may have resulted f rom 
a crossover event  between the la  class I RFLP (lane 2) and the 2a0 RFLP (lanes 
5-7) ,  since it shares bands with both  o f  these patterns.  Table  II gives a breakdown 
of  S16 class I -de f ined  EcoRI RFLPs in a populat ion of  BB, WF, and BBN rats 
that  also have the A-a lpha-def ined  type 2a RFLP.  All BB and BB-derived rats 
(n = 37) have the 2a0 class I (S16)-def ined RFLP (as do WF rats), while all BBN 
rats sharing the type 2a A-alpha RFLP (n = 20) can be distinguished as having 
the 2al  or  2a2 class I RFLP,  distinct f rom the 2a0 rats. In contrast  to our  
findings with the class II probes, where both  BB and some BBN rats shared the 
2a A-alpha RFLP,  the class I probe  absolutely distinguished BB rats (2a0) f rom 
BBN rats (2al ,  2a2, class I la  and lb)  (Fig. 1). 
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TABLE II 
Class I MHC Probe (S16)-defined RFLP Types in BB, BBN (2a), and 
WF Rats 
Chromosome type BBN (2a) (n) BB* (n) WF (n) 
2a0/2a0 0 36 8 
2al/2al 12 0 0 
2a2/2a2 I 0 0 
2al/2a2 7 0 0 
2a0/2al 0 0 0 
2a0/2a2 0 0 0 
* BB rats include 21 BB/O rats, 5 BB-Hooded rats, 4 BB/W rats from 
high incidence sublines, and 6 BB/W W-line rats. 
Breeding Study to Determine Diabetogenicity of RFLP-defined Chromosomes. BBN 
female rats with la, lb,  and 2a A-alpha-def ined RFLPs were mated with a single 
diabetic BB-Hooded  male rat for  a study o f  the segregation o f  MHC polymor- 
phisms with respect to the development  o f  diabetes. This strain of  diabetic rat  
was chosen because o f  its 95% incidence o f  diabetes. In the F~ animals der ived 
f rom these matings, we de te rmined  that the class I and II MHC RFLPs were 
inheri ted in a Mendelian fashion, as expected.  Namely, the offspring o f  a l a / l a  
by 2a0/2a0 mating were all l a /2a0 ,  et cetera. F~ rats were brother-sister mated 
to p roduce  F2 rats. 
F2 rats were screened for lymphopenia when 25 -35  d old using monoclonal  
ant ibody OX19,  as described in Materials and Methods. Overall, 131 of  557 
(23%) F2 rats were lymphopenic,  not  statistically different  f rom the 25% expected 
inheri tance o f  a recessive trait. T h e  inheri tance o f  lymphopenia was independent  
o f  the inheri tance o f  MHC RFLPs. In lymphopenic F2 rats in which RFLPs were 
de te rmined  (n --- 131), 17% were homozygous for BBN-derived RFLPs, 56% 
were heterozygous for BB-H and BBN-derived RFLPs, and 27% were bomozy- 
gous for  the BB-derived 2a0 RFLP (not statistically different  f rom the expected 
1:2:1 normal  distribution o f  a recessive trait). In nonlymphopenic  F2 rats in 
which RFLPs were de te rmined  (n = 96), the percent  distribution was 22:55:23 
(again, not statistically different  f rom that expected).  
T o  evaluate the diabetogenicity of  the MHC RFLPs, we followed lymphopenic 
Fz animals for  the deve lopment  of  glycosuria and hyperglycemia (>300 mg/dl  
serum glucose). O f  those that survived to 120 d o f  age, 13 developed DM. T h e  
breakdown of  the incidence of  diabetes as a function o f  BBN grandparental  A- 
a lpha-def ined  RFLP type demonst ra ted  (Table III) a significantly higher  inci- 
dence o f  diabetes in lymphopenic  F2 rats derived from 2a BBN matings than in 
those f rom la  or  lb  BBN matings, suggesting a diabetogenic effect o f  the 2a 
BBN MHC compared  with the la  or  lb  BBN MHC. 
T o  fur ther  define the MHC association o f  diabetes, we studied the class I (S 16) 
RFLPs in lymphopenic Fz rats who survived to 120 d of  age. T h e  incidence o f  
diabetes as a function o f  class I RFLP types is presented in Table  IV. T h e r e  was 
no statistical difference in the incidence o f  diabetes among the various 2a subtypes 
def ined by the class I probe.  Among  lymphopenic F2 rats that were homozygous 
for  the 2a0 (BB derived) class I RFLP,  28% (5 of  18) developed DM. Among  
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TABLE III 
Incidence of Diabetes Among Lymphopenic F9 Rats as a Function of BBN 
Grandparental Class II (A-Alpha) RFLP Type 
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BBN Grand- DM incidence 
parent A-alpha n 
RFLP No, Percent 
la 20 1 5.0 X ~ = 4.0, P < 0,05 
2a 29 8 27.6 X 2 = 4.5, P < 0,05 lb 45 4 8.9 
TABLE IV 
Class I (S16) RFLPs of Lymphopenic F2 Rats Surviving to 120 d of Age vs. Percent of Diabetes 
Mellitus 
Class 1 RFLP n 
Incidence of DM 
No. Percent 
BBMHC homozygotes 
BB/2a BBN MHC heterozygotes 
2a BBN MHChomozygotes 
BB/la or lb BBN MHC heterozygotes 
la or lb BBN MHC homozygotes 
2a0/2a0 18 5 27.8 
2a0/2al 8 3 37.5 
2a0/2a2 9 2 22.2 
17 5 29.4 
2al/2a2 3 2 66.7 
2a2/2a2 3 0 0 
6 2 33.3 
2a0/la 7 0 0 
2a0/lb 25 1 4.0 
32 1 3.1 
la/la 10 0 0 
lb/lb 11 0 0 
21 0 0 
lymphopenic 2a0 /2a l  and 2a0/2a2  rats (heterozygotes for BB[2a0]-and BBN 
[2al or  2a2]-derived MHC chromosomes),  29% (5 o f  17) developed DM. And 
among  lymphopenic 2 a l / 2 a 2  or  2a2/2a2 rats (homozygotes for BBN-derived 
MHC chromosomes),  33% (2 of  6) developed DM. These  findings indicate that 
the diabetogenic effect of  the BBN-derived 2al  and 2a2 MHC is similar to that 
of  BB-derived 2a0 MHC. In contrast, of  21 lymphopenic F2 rats homozygous  for 
the BBN-derived la  or l b  chromosome,  none developed DM, indicating a lack 
o f  diabetogenicity of  the la  or lb  MHC compared  with the 2a MHCs (×2 = 7.6; 
P < 0.01). 
Fur thermore ,  the MHC-linked diabetogenic gene seems to be functionally 
recessive, as only 3% (1 o f  32) lymphopenic F~ rats heterozygous for the 
nondiabetogenic  la  or  l b  MHC and the BB-derived 2a0 MHC developed 
diabetes, compared  with 29% (12 of  41) rats homo zygous for either the BB- or  
BBN-derived diabetogenic 2a MHC RFLP (X ~ = 8.4; P < 0.005). The  one l b /  
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TABLE V 
Serologic Typing of MHC RFLPs in BB and BBN Populations 
Class  I (S16)  A n t i -  A n t i -  A n t i -  A n t i -  
R F L P  R T 1  .A u R T 1  .A a R T 1  .B" R T 1 . D  a 
2 a 0 / 2 a 0  + - + - 
2 a l / 2 a l  + - + - 
2 a 2 / 2 a 2  + - + - 
l a / l a  - + - + 
l b / l b  . . . .  
2a0 rat that developed diabetes could not be bred, so we cannot exclude a 
recombination event in this animal. To summarize (see Fig. 1), the A-alpha class 
II probe allowed us to distinguish some of the control BBN rats from the 
diabetes-prone BB rats. The class I probe absolutely distinguished BB rats (2a0 
RFLP) from BBN rats (2al, 2a2, la, and lb class I RFLPs), enabling us to follow 
the segregation of BB vs. BBN MHC chromosomes in matings of BB and BBN 
rats. The breeding study demonstrates that there is an MHC-linked diabetogenic 
gene associated with the 2a A-alpha RFLP in the BB (2a0) as well as the BBN 
(2al and 2a2) control rat populations, but not with the la or lb RFLP. 
Serologic Determination of RTl Type of RFLP-defined BBN MHC Types. Using 
indirect immunofluorescence with monoclonal antibodies directed against class 
I MHC antigens (RT1.A a and RT1.A u) and class II MHC antigens (RT1.B u and 
RT1.Da), we determined the serologic RT1 type corresponding to the MHC 
RFLPs in the BB and BBN population (Table V). Briefly, l a / l a  rats expressed 
RT1 .A"D"; all 2a rats (2a0/2a0, 2a l /2a l ,  and 2a2/2a2) expressed RT1 .AUB u but 
not RT1.Da; and RFLP l b / l b  rats did not express RTI a nor RTI" at the loci 
tested. 
Discussion 
The BB rat develops type I diabetes of autoimmune etiology. Previous studies 
have identified two genes as contributing to the development of diabetes. One 
determines the T cell lymphopenia found in BB rats. The other is linked to RTI, 
the MHC of rats. To further define the molecular basis of the diabetogenic 
MHC-linked gene of BB rats, we studied RFLP in BB and BBN rats. BBN rats 
are an outbred strain of rats maintained as a closed colony in Ottawa, Canada 
and reflect the original commercial colony in which diabetes appeared and from 
which the various BB strains were developed. 
Using a class II A-alpha probe, we were able to distinguish four RFLP in the 
BBN population, only one of which (2a) has been found in three independently 
derived BB colonies. A DC-beta probe detected no additional polymorphisms 
that showed only linked polymorphisms homologous to the A-alpha RFLPs. An 
E-alpha probe also detected the same pattern of polymorphisms but only with 
two of four enzymes tested. Using an E-beta probe we were unable to detect any 
polymorphisms in the BBN or BB population. Mouse, human, and rat class II 
MHC genes exhibit considerable sequence homology (20) and these probes 
should recognize RT1.B-alpha, RT1.B-beta, RT1.D-alpha, and RT1.D-beta 
sequences, respectively (19, 22). Other investigators have detected limited poly- 
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morphism by RFLP analysis using class II probes (23). Our findings indicate 
otherwise, since four class II RFLP were found in a closed population using a 
single genomic probe (A-alpha) and two restriction enzymes. The degree of  
RFLP among class II gene sequences in the population studied seems to be: 
RT1.B-alpha _ RT1.B-beta > RT1.D-alpha >__ RT1.D-beta. In the H-2 system 
of mouse, the class II region has been divided into a relatively conserved I-E 
subregion and a more polymorphic I-A subregion. E-beta sequences span the 
boundary of  these two subregions and exhibit considerable RFLP, while E-alpha 
is in the conserved subregion and exhibits little RFLP (24). Therefore, it is 
surprising that in our rat population we could detect no polymorphisms using an 
E-beta probe; this suggests that the boundary between I suhregions of  rats may 
be shifted such that the E-beta equivalent (RT l.D-beta) is in the more conserved 
I-E subregion. The E-beta gene of  mouse is associated with a recombination "hot 
spot" that accounts for all intra-I region recombinants (24). It is interesting to 
note that the only I region recombinant in rats has mapped between the A-beta 
and A-alpha equivalents (23), supporting the notion that intra-class I! region 
dynamics may be difficult in the rat than in the mouse. 
We were unable to find any polymorphisms using mouse class III MHC probes. 
A class I probe (S16), however, identified many polymorphisms and could be 
used to absolutely distinguish BBN rats from BB rats. BBN rats that share A- 
alpha-defined 2a RFLPs can be subdivided into 2al and 2a2 forms, while all BB 
rats and BB-derived strains have a distinct form that we designated 2a0. The 
S16 class I probe should hybridize with both RT1.A and RT1.C/E sequences, 
areas coding for both classical class I major histocompatibility antigens and Qa- 
and Tl-like molecules. As in the mouse, most class I genes have been mapped to 
the right of  the class II region, the RT1.C/E loci (23). These class I -  and class 
II-defined RFLPs are inherited as tightly linked alleles (no evidence of  recom- 
bination using A-alpha and S16 probes in 123 F2 rats derived from la or lb  
BBN × 2a0 BB matings [two meiotic events]). 
A breeding study was carried out to evaluate the diabetogenicity of  the various 
MHC RFLP in the BB and BBN population. As expected, the BB-derived 2a0 
RFLP exerted a diabetogenic effect: 28% of  2a0 homozygous lymphopenic rats 
developed DM. Additionally, the 2al and 2a2 BBN-derived RFLP are diabeto- 
genic while the la and lb  BBN-derived RFLP are nondiabetogenic. Whether 
the diabetogenic gene in the BBN population is identical to that in BB rats is not 
known. The age of  onset of diabetes in 2a0/2a0 homozygous rats (n = 5) was 
115.4 + 7.7 d (mean +__ SEM); in 2a0/2al ,  2a0/2a2, or 2a l /2a2  diabetic rats (n 
= 7), the age of  onset was 88.4 +_ 8.0 d (P < 0.05 by two-tailed t test). These 
results suggest a form of synergism between the diabetogenic 2a0, 2al,  and 2a2 
MHC-bearing chromosomes, analogous to the earlier age of  onset of  diabetes in 
patients with type I diabetes and having the HLA DR3/DR4 haplotype (Dr. N. 
Maclaren, personal communication). However, there was no analogous higher 
incidence of  DM in 2a heterozygotes compared with 2a0/2a0 lymphopenic F2 
rats. 
The incidence of  diabetes in lymphopenic F2 rats homozygous for diabetogenic 
MHC-bearing chromosomes (type 2a0, 2al,  or 2a2) is ~10-fold higher (29%) 
than in lymphopenic F2 rats heterozygous for a nondiabetogenic halplotype (la 
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or lb) and the 2a0 diabetogenic haplotype (3%). We do not know if the one lb /  
2a0 rat that developed diabetes was the result of a crossover between the 
diabetogenic loci and the lb polymorphisms detected by RFLP analysis. In that 
case, the MHC-linked diabetogenic gene may be truly recessive. Alternatively, 
there may be a much lower incidence of diabetes among heterozygotes. In either 
case, the diabetogenic gene linked to the 2a MHC RFLP neither functions in 
the classic codominant fashion of MHC gene allele expression nor as a classic 
immune response gene, which usually confers responsiveness to foreign antigens 
in a dominant fashion. In the NOD mouse, another animal model of spontaneous 
autoimmune type I DM, there is also an MHC-linked diabetogenic gene that acts 
in a recessive manner (26). The same may be true of man since there is at least 
a fourfold increase in the incidence of overt diabetes in HLA identical siblings 
of patients with type I diabetes as compared with siblings having only one HLA 
haplotype in common with their diabetic sibling (27). 
The "recessiveness" of the diabetogenic influence of MHC genes can be 
explained by at least three mechanisms. If  the MHC-linked diabetogenic gene is 
a class II immune response gene, a decreased incidence of diabetes in heterozy- 
gotes may be due to decreased cell surface expression of the diabetogenic class 
II molecule on antigen-presenting cells, lymphocytes, or, possibly, the target 
tissue. Class II molecules are expressed as alpha:beta heterodimers. In F1 animals 
(heterozygotes for MHC genes), it has been shown that the alpha and beta chains 
can associate randomly, resulting in one-half to one-eighth the level of expression 
of a parental type heterodimer compared with the parental strain (28); further- 
more, the responsiveness of MHC-restricted T cell clones as proportional to the 
concentration of responder class II molecules (29). Alternatively, the anti-islet 
immune response involved in type I diabetes may be controlled by a class II 
immune "suppressor" gene. In such a system, low responsiveness is inherited as 
a dominant trait and high responsiveness as a recessive trait (30, 31). Finally, the 
MHC-linked gene involved in the pathogenesis of type I DM may code for 
deletion of an enzyme. For example, congenital adrenal hyperplasia results from 
a deficiency in a 21-hydroxylase involved in cortisol biosynthesis and is inherited 
as an MHC-linked autosomal recessive trait often associated with HLA-Bw47, 
C4A-null. Recent studies have defined the molecular basis of this disease associ- 
ation. The defect in 21-hydroxylation appears to be due to a deletion involving 
a P-450 21-hydroxylase in the MHC. This deletion may have also deleted part 
of the neighboring HLA-B and C4A regions, converting the common HLA-B 13, 
C4A3 haplotype to the rare HLA-Bw47, C4A-null haplotype (32). 
Serologic typing of class I (RT1.A) and class II (RT1 .B and RT1.D) antigens 
in BB and BBN rats showed that the diabetogenic 2a0, 2al,  and 2a2 MHC 
RFLPs code for the expression of RT 1 .AUB u while the nondiabetogenic la RFLP 
codes for RT1.AaD ~ and the nondiabetogenic lb RFLP codes for neither RTI" 
nor RTI", at the loci tested. Others have reported that BB rats express serologi- 
cally defined RT1 .A u antigens (6, 10) and that, among BBN rats, animals express 
RT1.A a and/or  RT1.A u (33). Examination of the class I ($16) RFLPs in Fig. 1 
shows that 2al RFLP (lane 4) may result from a crossover event between a 2a0 
(lanes 5-7) and a la (lane 2) MHC-bearing chromosome. It is significant that the 
2al RFLP codes for RT1.A°B u and not D a. Therefore, the hypothesized cross- 
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TABLE V I  
Comparison of the Incidence of Diabetes Among Lymphopenic F2 Rats as a Function of 
Grandparental Control Strain and MHC Type 
Control  strain: L* BN* WF* BBN la  BBN lb  BBN 2a 
R T 1  type 1 n u a Non-u  u 
n 88 237 63 20 45 29 
Percen t  DM 9.1 7.6 9.6 5.0 8.9 27.6* 
* L, BN, and  W F  refer  to Lewis, Brown Norway,  and  Wistar  Fur th  strains. Data for these rats were 
der ived f rom re fe rence  8 by dividing n by 4 to correct  for 25% incidence o f  lymphopenia ,  and  
recalculat ing the  pe rcen t  DM. 
* Significantly d i f ferent  f rom WF (X 2 = 5.0, P < 0.05). All o the r  di f ferences  f rom WF are  not  
statistically significant.  
over event that may have "created" the 2al MHC-bearing chromosome would 
have occurred on the RT1.C side of RT1.D, and the diabetogenic MHC-linked 
gene would be on the class II side of the crossover. 
A possible interpretation of  the results of  the breeding program is that the 
serologically defined RT1 u contributes to the development of diabetes in BB 
rats. However, data from our previous breeding study suggests otherwise (Table 
VI). In that study, the incidence of diabetes in F2 rats derived from WF x BB 
crosses was similar to the incidence in Brown Norway × BB and Lewis x BB F2 
rats as well as in F2 rats derived from la × BB and lb  x BB crosses (9), although 
WF rats are serologically and MHC RFLP identical to BB rats using both class 
I -  and II-specific reagents. The incidence of diabetes in F2 rats derived from 
2al or 2a2 BBN X BB crosses (when both grandparents carried diabetogenic 
MHC genes) was three- to fivefold higher. Previously, it was impossible to directly 
test the diabetogenicity of the WF RTP because it is indistinguishable from the 
BB RTP.  With the availability of  class I-defined 2a 1 and 2a2 diabetogenic MHC 
RFLPs, the diabetogenicity of  the potentially nondiabetogenic WF (2a0) MHC 
can now be directly assessed in breeding studies. 
The availability of  three diabetogenic MHC types should be of value in 
localizing and defining the diabetogenic MHC-linked gene in the rat. Because of 
its similarities to the MHC-linked diabetogenic gene in the NOD mouse and 
man, these studies may provide data with more general implications for the role 
of  the MHC in DM and other autoimmune diseases. 
S u m m a r y  
Class I and II major histocompatibility complex (MHC) probes can be used to 
subdivide diabetes-prone BB rats and their BBN control strain, coderived from 
the same outbred colony by selection against diabetes. Class II probes (A-alpha 
in particular) distinguish four restriction fragment length polymorphisms 
(RFLP), termed la, lb, 2a, and 2b, in the BBN population, only one of which 
(2a) is found in BB rats. The degree of class II RFLP in the population studied 
is RT1.B-alpha _ RT1.B-beta > RT1.D-alpha - RT1.D-beta, suggesting that 
intra-class II region dynamics may be different in rats compared with mice. A 
class I probe (S 16) absolutely distinguished BB from BBN rats, since all BB rats 
exhibit an RFLP pattern termed 2a0, while 2a BBN rats can be subdivided into 
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2al  and 2a2 forms. Serologic evaluation has shown that  2a0, 2a l ,  and 2a2 rats 
express RT1 .A"B °, l a  rats express RT1.AaD a, and l b  rats express nei ther  RTI" 
nor  RTl  ° at the loci tested. A breed ing  study was carr ied out  to de te rmine  the 
diabetogenici ty  o f  the MHC-def ined  RFLP's .  As expected,  the BB-derived 2a0 
is diabetogenic.  T h e  BBN-der ived 2al  and 2a2 RFLPs are  also diabetogenic,  
while la  and  l b  rats do not carry MHC-l inked diabetogenic  genes. T h e  MHC-  
linked diabetes gene acts in a functionally recessive manner ,  since there  is a 10- 
fold higher  incidence in homozygotes  than in heterozygotes .  Analysis o f  the 
RFLP  pat terns  leads us to hypothesize that  the 2al  RFLP  results f rom a crossover  
between la  and 2a0 MHCs  and that  the diabetogenic  MHC-l inked gene is on 
the class I I  side of  Qa and Tl. T h e  availability of  three  diabetogenic  M H C  
haplotypes should help localize the MHC-l inked diabetogenic gene  o f  rats. 
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